GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » 12-1 Month Momentum %

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) 12-1 Month Momentum % : 6.84% (As of May. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-26), Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % is 6.84%.

The industry rank for Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % or its related term are showing as below:

SHSE:688513's 12-1 Month Momentum % is ranked better than
73.73% of 1477 companies
in the Biotechnology industry
Industry Median: -25.71 vs SHSE:688513: 6.84

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum %

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % falls into.



Chengdu Easton Biopharmaceuticals Co  (SHSE:688513) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Easton Biopharmaceuticals Co  (SHSE:688513) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Chengdu Easton Biopharmaceuticals Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines